Skip to main navigation
Skip to search
Skip to main content
Prinses Máxima Centrum Home
Nederlands
English
Search content at Prinses Máxima Centrum
Home
Profiles
Research Groups
Equipment
Research output
Prizes
Activities
Press/Media
Solubility and bioavailability improvement of pazopanib hydrochloride
Maikel Herbrink
, Stefanie L. Groenland
,
Alwin D.R. Huitema
, Jan H.M. Schellens
, Jos H. Beijnen
, Neeltje Steeghs
, Bastiaan Nuijen
Research output
:
Contribution to journal
›
Article
›
peer-review
29
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Solubility and bioavailability improvement of pazopanib hydrochloride'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pazopanib Hydrochloride
100%
Solubility Enhancement
100%
Bioavailability Improvement
100%
Dissolution Properties
50%
New Drugs
25%
In Cancer
25%
Anticancer Drugs
25%
Cancer Patients
25%
Therapeutic Efficacy
25%
Dose Escalation
25%
Oral Bioavailability
25%
Microscopic Techniques
25%
Low Variability
25%
Pharmaceutical Formulations
25%
Aqueous Solubility
25%
In Vitro Dissolution
25%
Powder Mixture
25%
PH-switchable
25%
Enhanced Solubility
25%
Mixture Formulation
25%
Wet Milling
25%
Mixing Technique
25%
Wet Mixing
25%
Soluplus
25%
Votrient
25%
Milling Process
25%
Block Polymer
25%
Thermal Methods
25%
Dissolution Model
25%
Polymeric Excipients
25%
Spectrometric Techniques
25%
Pharmacology, Toxicology and Pharmaceutical Science
Bioavailability
100%
Pazopanib
100%
Malignant Neoplasm
20%
Combination Therapy
20%
Anticarcinogen
20%
Excipient
20%